GlassScriptPhysician profile
Van A Gauby
NPI 1811945355
$882.29
in general payments reported to CMS, 2019-2025
19 companies · $210 in 2025
The $210 reported for 2025 was more than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $13.80 · 2021: $105 · 2022: $62.96 · 2023: $148 · 2024: $342 · 2025: $210.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $700.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $700.08 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $280.41 | 2023-2025 | Airsupra, Breztri, Evusheld |
| Glaxosmithkline, LLC. | $93.71 | 2021-2025 | Trelegy Ellipta, Shingrix, Boostrix |
| Sumitomo Pharma America, INC. | $57.35 | 2024-2025 | Gemtesa |
| Exact Sciences Corporation | $52.12 | 2024-2025 | Cologuard Collection Kit |
| Pfizer INC. | $51.99 | 2021-2025 | |
| Novo Nordisk INC | $49.31 | 2021-2025 | |
| Xeris Pharmaceuticals, INC. | $45.96 | 2023 | Keveyis |
| Lilly USA, LLC | $36.97 | 2021-2025 | Mounjaro, Zepbound |
| Vital Connect, INC | $25.92 | 2023 | Vitalpatch Rtm |
| Ani Pharmaceuticals, INC. | $24.93 | 2024 | Purified Cortrophin Gel |
| Abbvie INC. | $24.51 | 2023 | |
| Boston Scientific Corporation | $22.37 | 2025 | General - Therapies |
| Otsuka America Pharmaceutical, INC. | $21.18 | 2024 | Nuedexta |
| Abbott Laboratories | $20.02 | 2021 | |
| Bayer Healthcare Pharmaceuticals INC. | $18.83 | 2022 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $18.82 | 2025 | Otezla, Repatha |
| Strongbridge US INC. | $13.80 | 2019 | |
| Genentech USA, INC. | $12.65 | 2021 | |
| Vbi Vaccine (Delaware) INC. | $11.44 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Van Gauby listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.